FDA survey finds Americans don’t really understand drug approvals

17 December 2019 - Only about one quarter (25.1%) of Americans understand that a new drug approved by the US ...

Read more →

Physicians’ perspectives on FDA approval standards and off-label drug marketing

22 January 2019 - Recently, two fundamental aspects of the US FDA’s pharmaceutical market oversight have become controversial.  ...

Read more →

Deloitte survey finds biopharma companies are accelerating adoption of real-world evidence

28 June 2018 - A recent survey shows that 90% of biopharma companies are making significant investments in real-world evidence ...

Read more →